Intervention Protocol

Intensive versus conventional glycaemic control for treating diabetic foot ulcers

  1. Malindu E Fernando1,2,*,
  2. Ridmee M Seneviratne1,
  3. Margaret Cunningham1,
  4. Peter A Lazzarini3,4,
  5. Kunwarjit S Sangla5,
  6. Yong Mong Tan5,
  7. Petra G Buttner6,
  8. Jonathan Golledge1,7

Editorial Group: Cochrane Wounds Group

Published Online: 11 OCT 2013

DOI: 10.1002/14651858.CD010764


How to Cite

Fernando ME, Seneviratne RM, Cunningham M, Lazzarini PA, Sangla KS, Tan YM, Buttner PG, Golledge J. Intensive versus conventional glycaemic control for treating diabetic foot ulcers (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010764. DOI: 10.1002/14651858.CD010764.

Author Information

  1. 1

    School of Medicine and Dentistry, James Cook University, Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, Townsville, Queensland, Australia

  2. 2

    Kirwan Community Health Campus, Department of Podiatry, Townsville, Queensland, Australia

  3. 3

    Queensland Health, Allied Health Research Collaborative, Herston, Brisbane, Queensland, Australia

  4. 4

    Queensland University of Technology, School of Clinical Sciences, Brisbane, Queensland, Australia

  5. 5

    The Townsville Hospital, Department of Diabetes and Endocrinology, Townsville, Queensland, Australia

  6. 6

    James Cook University, School of Public Health and Tropical Medicine, Townsville, Queensland, Australia

  7. 7

    The Townsville Hospital, Department of Vascular and Endovascular Surgery, Townsville, Queensland, Australia

*Malindu E Fernando, Department of Podiatry, Kirwan Community Health Campus, Townsville, Queensland, Australia. malindu.fernando@my.jcu.edu.au.

Publication History

  1. Publication Status: New
  2. Published Online: 11 OCT 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of intensive glycaemic control compared to conventional control on the outcome of foot ulcers in patients with type 1 and type 2 diabetes.